Notices / Press Releases other Statutory Communication



2016-17
December 31, 2016
Newspaper Advertisement of Q3FY17 (Business Standard and Sakal) Notice of Board meeting – Newspaper Advertisement Notice of Board Meeting Corporate Governance Report as on December 31, 2016 Reconciliation of Share Capital as on December 31, 2016 Statement of Investor Complaints Pursuant to Regulation 13(3) for Quarter December 31, 2016

September 30, 2016
Corporate Governance Report as on September 30, 2016 Reconciliation of Share Capital as on September 30, 2016 Certificate under regulation 40(9) & 40 (10) as on September 30, 2016 Statement of Investor Complaints Pursuant to Regulation 13(3) for Quarter September 30, 2016 Compliance Certificate - Regulation 7(3) as on September 30, 2016 Notice of Board Meeting Newspaper Advertisement of the Board meeting (Pratyaksha) Newspaper Advertisement of the Board meeting (Business Standard)

August 13, 2016
Newspaper Advertisement on Postal Ballot
August 9, 2016
Notice of Postal Ballot under Section 180 (1)(a) of Companies Act, 2013

July 28, 2016
Familiarization Programme for the Independent Directors during the financial year 2016-2017

July 26, 2016
Proceedings of 53Rd Annual General Meeting

July 23, 2016
New Paper Advertisement of the Board Meeting notice 53rd Annual General Meeting Voting Results and Scrutinizer's report

July 23, 2016
Notice of Board Meeting

June 30, 2016
Corporate Governance Report as on June 30, 2016 Reconciliation of Share Capital as on June 30, 2016Statement of Investor Complaints Pursuant to Regulation 13(3) for Quarter June 30, 2016

June 25, 2016
Newspaper Advertisement of Book Closure and e- Voting of the 53rd Annual General Meeting

June 24, 2016
Unichem Laboratories receives ANDA approval from USFDA for Donepezil Hydrochloride Tablets USP

June 22, 2016
Notice of 53rd Annual General Meeting, remote E-voting and Book Closure

May 20, 2016
Notice of Board Meeting

April 21, 2016
Notice of Board Meeting

April 19, 2016
Notice of Board Meeting

2015-16
March 31, 2016
Corporate Governance Report as on March 31, 2016 Reconciliation of Share Capital as on March, 2016 Certificate under regulation 40(9) & 40 (10) as on March 31, 2016 Statement of Investor Complaints Pursuant to Regulation 13(3) for Quarter March 31, 2016 Compliance Certificate - Regulation 7(3) as on March 31, 2016

April 04, 2016
Details of Familiarization Programs conducted during the year 2015-2016

March 09, 2016
Outcome Of Board Meeting
Unichem Laboratories receives Final ANDA approval from USFDA for Quetiapine Fumarate Tablets

January 29, 2016
Unichem Laboratories receives Final ANDA approval from USFDA for Alfuzosin Hydrochloride Extended-Release Tablets USP

March 03, 2016
Intimation Of Board Meeting

January 29, 2016
Unichem Laboratories receives Final ANDA approval from USFDA for Alfuzosin Hydrochloride Extended-Release Tablets USP

December 8, 2015
Unichem Laboratories receives Final ANDA approval from USFDA for Irbesartan Teblets USP

December 1, 2015
Contact Details of the Authorised Key Managerial Personnel under Regulation 30 (5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

October 16, 2015
Unichem Laboratories receives ANDA approval from USFDA for Losartan Potassium Tablets USP

October 14, 2015
Unichem Laboratories receives Final ANDA approval from USFDA for Memantine Hydrochloride Tablets USP

October 12, 2015
Clarification on news article Company plans sale of its Domestic Formulations business

October 09, 2015
Unichem Laboratories receives ANDA approval from USFDA for MONTELUKAST SODIUM TABLETS

July 11, 2015
52nd ANNUAL GENERAL MEETING
Notice of 52nd Annual General Meeting, Remote E-Voting and Book Closure Consolidated Report on the Result of remote E-Voting and voting at the meeting through poll (physical ballot) Disclosures regarding voting results of the said Meeting as per Clause 35A of the Listing Agreement

July 12, 2014
51nd ANNUAL GENERAL MEETING
51ST Annual General Meeting Results held on July 12, 2014